Rocephin and Bedridden - a phase IV clinical study of FDA data
Summary:
We study 30,552 people who take Rocephin (ceftriaxone sodium) or have Bedridden. No report of Bedridden is found in people who take Rocephin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
What is Bedridden?
Bedridden is found to be associated with 971 drugs and 1,094 conditions by eHealthMe. Check the latest studies of Bedridden.
No report is found.
Do you take Rocephin and have Bedridden?
- Check whether Bedridden is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rocephin:
- Rocephin (15,665 reports)
Bedridden treatments and more:
- Bedridden (14,887 reports)
How severe was Bedridden and when was it recovered:
Expand to all the drugs that have ingredients of ceftriaxone sodium:
Browse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bedridden:
Browse all the conditions that are associated with Bedridden:
Drugs similar to Rocephin and Bedridden :
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Rocephin) and Rocephin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Jardiance and Janumet drug interactions for men aged 50-59 - 3 seconds ago
- Could Duloxetine Hydrochloride cause Foot Deformity? - 13 seconds ago
- Could B12 cause Malaise? - 16 seconds ago
- Could Cogentin cause Nausea And Vomiting? - 18 seconds ago
- Could Jentadueto cause General Physical Health Deterioration? - 25 seconds ago
- Could Nitro-Bid cause Pain Exacerbated? - 32 seconds ago
- Could Leflunomide cause High Blood Pressure? - 47 seconds ago
- Benadryl and Sciatic Nerve Dysfunction for Men aged 50-59 - 49 seconds ago
- Benadryl and Neuropathy - Sciatic Nerve for Men aged 50-59 - 49 seconds ago
- Benadryl and Sciatica for Men aged 50-59 - 49 seconds ago